1-17 of 17
cd20 antigens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The selection of variable regions affects effector mechanisms of IgA antibodies against CD20

Mitchell Evers, Thies Rösner, Anna Dünkel, J. H. Marco Jansen, Niklas Baumann, Toine ten Broeke, Maaike Nederend, Klara Eichholz, Katja Klausz, Karli Reiding, Denis M. Schewe, Christian Kellner, Matthias Peipp, Jeanette H. W. Leusen, Thomas Valerius
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3807–3820.
https://doi.org/10.1182/bloodadvances.2021004598
Published: 2021
Includes: Supplemental data
Journal Articles

Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Hasmukh Jain, Manju Sengar, Vasu Babu Goli, Jayashree Thorat, Prashant Tembhare, Dhanlaxmi Shetty, V. N. Avinash Bonda, Lingaraj Nayak, P. G. Subramanian, Bhausaheb Bagal, Nikhil Patkar, Neha Sharma, Himanshi Gupta, Sumeet Gujral
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3436–3444.
https://doi.org/10.1182/bloodadvances.2020003368
Published: 2021
Journal Articles

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, Y. Tabib, Y. C. Cohen, N. Benyamini, O. Beyar-Katz, M. Neaman, R. Vitkon, N. Keren-Khadmy, M. Levin, Y. Herishanu, I. Avivi
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3053–3061.
https://doi.org/10.1182/bloodadvances.2021005094
Published: 2021
Journal Articles

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

Clinical Trials & Observations
Abi Vijenthira, Inna Gong, Stephen D. Betschel, Matthew Cheung, Lisa K. Hicks
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2624–2643.
https://doi.org/10.1182/bloodadvances.2021004629
Published: 2021
Includes: Supplemental data
Journal Articles

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Yasunori Ueda, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Kosei Matsue, Tomohiro Kinoshita, Go Yamamoto, Shuichi Taniguchi, Shigeru Chiba, Koichi Ohshima, Koji Izutsu
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4442–4450.
https://doi.org/10.1182/bloodadvances.2020002293
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 1/2a study of 177 Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Clinical Trials & Observations
Arne Kolstad, Tim Illidge, Nils Bolstad, Signe Spetalen, Ulf Madsbu, Caroline Stokke, Johan Blakkisrud, Ayca Løndalen, Noelle O'Rourke, Matthew Beasley, Wojciech Jurczak, Unn-Merete Fagerli, Michal Kaščák, Mike Bayne, Aleš Obr, Jostein Dahle, Lisa Rojkjaer, Veronique Pascal, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4091–4101.
https://doi.org/10.1182/bloodadvances.2020002583
Published: 2020
Includes: Supplemental data
Journal Articles

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Christopher K. Rushton, Sarah E. Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, Nicole Thomas, Laura K. Hilton, Neil Michaud, Scott Daigle, Jordan Davidson, Kevin Bushell, Stephen Yu, Ryan N. Rys, Michael Jain, Lois Shepherd, Marco A. Marra, John Kuruvilla, Michael Crump, Koren Mann, Sarit Assouline, Joseph M. Connors, Christian Steidl, Mark S. Cragg, David W. Scott, Nathalie A. Johnson, Ryan D. Morin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2886–2898.
https://doi.org/10.1182/bloodadvances.2020001696
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA

Clinical Trials & Observations
Sarah C. Rutherford, Michael Herold, Wolfgang Hiddemann, Lale Kostakoglu, Robert Marcus, Maurizio Martelli, Laurie H. Sehn, Marek Trněný, Judith Trotman, Umberto Vitolo, Tina Nielsen, Federico Mattiello, Deniz Sahin, Gila Sellam, Peter Martin
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1589–1593.
https://doi.org/10.1182/bloodadvances.2019001261
Published: 2020
Includes: Supplemental data
Journal Articles

Carden MA, Gaddh M, Hoskote A, et al. Rituximab leads to early elimination of circulating CD20 + T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020;4(3):477-481.

Journal: Blood Advances
Blood Adv (2020) 4 (6): 1093.
https://doi.org/10.1182/bloodadvances.2020001818
Published: 2020
Journal Articles

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum

Clinical Trials & Observations
Andrés J. M. Ferreri, Marianna Sassone, Elisabetta Miserocchi, Silvia Govi, Caterina Cecchetti, Matteo E. Corti, Silvia Mappa, Luca Arcaini, Francesco Zaja, Giuseppe Todeschini, Donato Mannina, Teresa Calimeri, Salvatore Perrone, Maurilio Ponzoni, Giulio Modorati
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1013–1019.
https://doi.org/10.1182/bloodadvances.2020001459
Published: 2020
Journal Articles

Rituximab leads to early elimination of circulating CD20 + T and B lymphocytes in patients with iTTP despite ongoing TPEx

Marcus A. Carden, Manila Gaddh, Abhinav Hoskote, Michael Brown, Virginia Merrill, Sean R. Stowell, Shanmuganathan Chandrakasan, Ana Antun, Ragini Kudchadkar, Sarah Kotanchiyev, David L. Jaye, Imre Bodó
Journal: Blood Advances
Blood Adv (2020) 4 (3): 477–481.
https://doi.org/10.1182/bloodadvances.2019001148
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation

Clinical Trials & Observations
Taiki Ando, Takayoshi Tachibana, Masatsugu Tanaka, Taisei Suzuki, Yasufumi Ishiyama, Satoshi Koyama, Eriko Ogusa, Ayumi Numata, Kenji Matsumoto, Heiwa Kanamori, Hideaki Nakajima
Journal: Blood Advances
Blood Adv (2020) 4 (2): 408–419.
https://doi.org/10.1182/bloodadvances.2019001021
Published: 2020
Includes: Supplemental data
Journal Articles

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Clinical Trials & Observations
Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, Paul M. Barr, Frederick Lansigan, Bruce D. Cheson, Arun K. Singavi, Maryam Sarraf Yazdy, Nirav N. Shah, John N. Allan, Erica B. Bhavsar, Joanna Rhodes, Kaitlin Kennard, Stephen J. Schuster, AnnaLynn M. Williams, Alan P. Skarbnik, Andre H. Goy, Julie M. Goodfriend, Colleen Dorsey, Catherine C. Coombs, Hande Tuncer, Chaitra S. Ujjani, Ryan Jacobs, Allison M. Winter, John M. Pagel, Neil Bailey, Anna Schuh, Mazyar Shadman, Andrea Sitlinger, Hanna Weissbrot, Sivraj Muralikrishnan, Andrew Zelenetz, Amy A. Kirkwood, Christopher P. Fox
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1568–1573.
https://doi.org/10.1182/bloodadvances.2019000180
Published: 2019
Journal Articles

Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib

Emily M. McWilliams, Christopher R. Lucas, Timothy Chen, Bonnie K. Harrington, Ronni Wasmuth, Amanda Campbell, Kerry A. Rogers, Carolyn M. Cheney, Xiaokui Mo, Leslie A. Andritsos, Farrukh T. Awan, Jennifer Woyach, William E. Carson, III, Jonathan Butchar, Susheela Tridandapani, Erin Hertlein, Carlos E. Castro, Natarajan Muthusamy, John C. Byrd
Journal: Blood Advances
Blood Adv (2019) 3 (3): 447–460.
https://doi.org/10.1182/bloodadvances.2018025684
Published: 2019
Includes: Supplemental data
Journal Articles

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

Clinical Trials & Observations
Monika Pilichowska, Stefania Pittaluga, Judith A. Ferry, Jessica Hemminger, Hong Chang, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, Jeremy S. Abramson, Athena Kritharis, Francisco J. Hernandez-Ilizaliturri, Izidore S. Lossos, Oliver W. Press, Timothy S. Fenske, Jonathan W. Friedberg, Julie M. Vose, Kristie A. Blum, Deepa Jagadeesh, Bruce Woda, Gaurav K. Gupta, Randy D. Gascoyne, Elaine S. Jaffe, Andrew M. Evens
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2600–2609.
https://doi.org/10.1182/bloodadvances.2017009472
Published: 2017
Includes: Supplemental data
Journal Articles

Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates

Jean Kwun, Christopher Burghuber, Miriam Manook, Brian Ezekian, Jaeberm Park, Janghoon Yoon, John S. Yi, Neal Iwakoshi, Adriana Gibby, Jung Joo Hong, Alton B. Farris, Allan D. Kirk, Stuart J. Knechtle
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2115–2119.
https://doi.org/10.1182/bloodadvances.2017010991
Published: 2017
Includes: Supplemental data
Journal Articles

Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies

Elias Jabbour, Hagop Kantarjian
Journal: Blood Advances
Blood Adv (2016) 1 (3): 260–264.
https://doi.org/10.1182/bloodadvances.2016000042
Published: 2016